ブデソニド（BUD）の世界市場（～2026年）

• 英文タイトル：Global Budesonide (BUD) Market Insights and Forecast to 2026

• レポートコード：MRC2-11QY03509 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、113ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬

• 販売価格（消費税別）

Single User	￥585,000 (USD3,900)	▷ お問い合わせ
Multi User	￥877,500 (USD5,850)	▷ お問い合わせ
Enterprise License	￥1,170,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

当調査資料はブデソニド（BUD）のグローバル市場について調査・分析したレポートです。種類別（点鼻薬、吸入器、ピル・直腸フォーム）市場規模、用途別（呼吸器疾患治療、鼻疾患治療、炎症性腸疾患治療）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別ブデソニド（BUD）の競争状況、市場シェア ・世界のブデソニド（BUD）市場：種類別市場規模 2015年-2020年（点鼻薬、吸入器、ピル・直腸フォーム） ・世界のブデソニド（BUD）市場：種類別市場規模予測 2021年-2026年（点鼻薬、吸入器、ピル・直腸フォーム） ・世界のブデソニド（BUD）市場：用途別市場規模 2015年-2020年（呼吸器疾患治療、鼻疾患治療、炎症性腸疾患治療） ・世界のブデソニド（BUD）市場：用途別市場規模予測 2021年-2026年（呼吸器疾患治療、鼻疾患治療、炎症性腸疾患治療） ・北米のブデソニド（BUD）市場分析：米国、カナダ ・ヨーロッパのブデソニド（BUD）市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアのブデソニド（BUD）市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米のブデソニド（BUD）市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカのブデソニド（BUD）市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：AstraZeneca、Cosmo Pharmaceuticals、Teva、Mylan、Sandoz、Dr. Falk Pharma、Chiesi Farmaceutici S.p.A、Orion Corporation、Cipla、Synmosa Biopharma Corporation、Lunan Better Pharmaceutical、Shanghai Sine Promod Pharmaceutical ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論

Market Analysis and Insights: Global Budesonide (BUD) Market
The global Budesonide (BUD) market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.

Global Budesonide (BUD) Scope and Market Size
Budesonide (BUD) market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Budesonide (BUD) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.

Segment by Type, the Budesonide (BUD) market is segmented into
Nasal Spray
Inhaler
Pill&Rectal Forms

Segment by Application, the Budesonide (BUD) market is segmented into
Respiratory Disease Treatment
Nose Disease Treatment
Inflammatory Bowel Disease Treatment

Regional and Country-level Analysis
The Budesonide (BUD) market is analysed and market size information is provided by regions (countries).
The key regions covered in the Budesonide (BUD) market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Budesonide (BUD) Market Share Analysis
Budesonide (BUD) market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Budesonide (BUD) business, the date to enter into the Budesonide (BUD) market, Budesonide (BUD) product introduction, recent developments, etc.

The major vendors covered:
AstraZeneca
Cosmo Pharmaceuticals
Teva
Mylan
Sandoz
Dr. Falk Pharma
Chiesi Farmaceutici S.p.A
Orion Corporation
Cipla
Synmosa Biopharma Corporation
Lunan Better Pharmaceutical
Shanghai Sine Promod Pharmaceutical

レポート目次

---

1 Study Coverage
1.1 Budesonide (BUD) Product Introduction
1.2 Market Segments
1.3 Key Budesonide (BUD) Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Budesonide (BUD) Market Size Growth Rate by Type
1.4.2 Nasal Spray
1.4.3 Inhaler
1.4.4 Pill&Rectal Forms
1.5 Market by Application
1.5.1 Global Budesonide (BUD) Market Size Growth Rate by Application
1.5.2 Respiratory Disease Treatment
1.5.3 Nose Disease Treatment
1.5.4 Inflammatory Bowel Disease Treatment
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Global Budesonide (BUD) Market Size, Estimates and Forecasts
2.1.1 Global Budesonide (BUD) Revenue 2015-2026
2.1.2 Global Budesonide (BUD) Sales 2015-2026
2.2 Global Budesonide (BUD), Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Budesonide (BUD) Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Budesonide (BUD) Retrospective Market Scenario in Revenue by Region: 2015-2020

3 Global Budesonide (BUD) Competitor Landscape by Players
3.1 Budesonide (BUD) Sales by Manufacturers
3.1.1 Budesonide (BUD) Sales by Manufacturers (2015-2020)
3.1.2 Budesonide (BUD) Sales Market Share by Manufacturers (2015-2020)
3.2 Budesonide (BUD) Revenue by Manufacturers
3.2.1 Budesonide (BUD) Revenue by Manufacturers (2015-2020)
3.2.2 Budesonide (BUD) Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Budesonide (BUD) Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Budesonide (BUD) Revenue in 2019
3.2.5 Global Budesonide (BUD) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Budesonide (BUD) Price by Manufacturers
3.4 Budesonide (BUD) Manufacturing Base Distribution, Product Types
3.4.1 Budesonide (BUD) Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Budesonide (BUD) Product Type
3.4.3 Date of International Manufacturers Enter into Budesonide (BUD) Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
4.1 Global Budesonide (BUD) Market Size by Type (2015-2020)
4.1.1 Global Budesonide (BUD) Sales by Type (2015-2020)
4.1.2 Global Budesonide (BUD) Revenue by Type (2015-2020)
4.1.3 Budesonide (BUD) Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Budesonide (BUD) Market Size Forecast by Type (2021-2026)
4.2.1 Global Budesonide (BUD) Sales Forecast by Type (2021-2026)
4.2.2 Global Budesonide (BUD) Revenue Forecast by Type (2021-2026)
4.2.3 Budesonide (BUD) Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Budesonide (BUD) Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Market Size by Application (2015-2026)
5.1 Global Budesonide (BUD) Market Size by Application (2015-2020)
5.1.1 Global Budesonide (BUD) Sales by Application (2015-2020)
5.1.2 Global Budesonide (BUD) Revenue by Application (2015-2020)
5.1.3 Budesonide (BUD) Price by Application (2015-2020)
5.2 Budesonide (BUD) Market Size Forecast by Application (2021-2026)
5.2.1 Global Budesonide (BUD) Sales Forecast by Application (2021-2026)
5.2.2 Global Budesonide (BUD) Revenue Forecast by Application (2021-2026)
5.2.3 Global Budesonide (BUD) Price Forecast by Application (2021-2026)

6 North America
6.1 North America Budesonide (BUD) by Country
6.1.1 North America Budesonide (BUD) Sales by Country
6.1.2 North America Budesonide (BUD) Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Budesonide (BUD) Market Facts & Figures by Type
6.3 North America Budesonide (BUD) Market Facts & Figures by Application

7 Europe
7.1 Europe Budesonide (BUD) by Country
7.1.1 Europe Budesonide (BUD) Sales by Country
7.1.2 Europe Budesonide (BUD) Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Budesonide (BUD) Market Facts & Figures by Type
7.3 Europe Budesonide (BUD) Market Facts & Figures by Application

8 Asia Pacific
8.1 Asia Pacific Budesonide (BUD) by Region
8.1.1 Asia Pacific Budesonide (BUD) Sales by Region
8.1.2 Asia Pacific Budesonide (BUD) Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Budesonide (BUD) Market Facts & Figures by Type
8.3 Asia Pacific Budesonide (BUD) Market Facts & Figures by Application

9 Latin America
9.1 Latin America Budesonide (BUD) by Country
9.1.1 Latin America Budesonide (BUD) Sales by Country
9.1.2 Latin America Budesonide (BUD) Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Budesonide (BUD) Market Facts & Figures by Type
9.3 Central & South America Budesonide (BUD) Market Facts & Figures by Application

10 Middle East and Africa
10.1 Middle East and Africa Budesonide (BUD) by Country
10.1.1 Middle East and Africa Budesonide (BUD) Sales by Country
10.1.2 Middle East and Africa Budesonide (BUD) Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Budesonide (BUD) Market Facts & Figures by Type
10.3 Middle East and Africa Budesonide (BUD) Market Facts & Figures by Application

11 Company Profiles
11.1 AstraZeneca
11.1.1 AstraZeneca Corporation Information
11.1.2 AstraZeneca Description and Business Overview
11.1.3 AstraZeneca Sales, Revenue and Gross Margin (2015-2020)
11.1.4 AstraZeneca Budesonide (BUD) Products Offered
11.1.5 AstraZeneca Related Developments
11.2 Cosmo Pharmaceuticals
11.2.1 Cosmo Pharmaceuticals Corporation Information
11.2.2 Cosmo Pharmaceuticals Description and Business Overview
11.2.3 Cosmo Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Cosmo Pharmaceuticals Budesonide (BUD) Products Offered
11.2.5 Cosmo Pharmaceuticals Related Developments
11.3 Teva
11.3.1 Teva Corporation Information
11.3.2 Teva Description and Business Overview
11.3.3 Teva Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Teva Budesonide (BUD) Products Offered
11.3.5 Teva Related Developments
11.4 Mylan
11.4.1 Mylan Corporation Information
11.4.2 Mylan Description and Business Overview
11.4.3 Mylan Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Mylan Budesonide (BUD) Products Offered
11.4.5 Mylan Related Developments
11.5 Sandoz
11.5.1 Sandoz Corporation Information
11.5.2 Sandoz Description and Business Overview
11.5.3 Sandoz Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Sandoz Budesonide (BUD) Products Offered
11.5.5 Sandoz Related Developments
11.6 Dr. Falk Pharma
11.6.1 Dr. Falk Pharma Corporation Information
11.6.2 Dr. Falk Pharma Description and Business Overview
11.6.3 Dr. Falk Pharma Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Dr. Falk Pharma Budesonide (BUD) Products Offered
11.6.5 Dr. Falk Pharma Related Developments
11.7 Chiesi Farmaceutici S.p.A
11.7.1 Chiesi Farmaceutici S.p.A Corporation Information
11.7.2 Chiesi Farmaceutici S.p.A Description and Business Overview
11.7.3 Chiesi Farmaceutici S.p.A Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Chiesi Farmaceutici S.p.A Budesonide (BUD) Products Offered
11.7.5 Chiesi Farmaceutici S.p.A Related Developments
11.8 Orion Corporation
11.8.1 Orion Corporation Corporation Information
11.8.2 Orion Corporation Description and Business Overview
11.8.3 Orion Corporation Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Orion Corporation Budesonide (BUD) Products Offered
11.8.5 Orion Corporation Related Developments
11.9 Cipla
11.9.1 Cipla Corporation Information
11.9.2 Cipla Description and Business Overview
11.9.3 Cipla Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Cipla Budesonide (BUD) Products Offered
11.9.5 Cipla Related Developments
11.10 Synmosa Biopharma Corporation
11.10.1 Synmosa Biopharma Corporation Corporation Information
11.10.2 Synmosa Biopharma Corporation Description and Business Overview
11.10.3 Synmosa Biopharma Corporation Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Synmosa Biopharma Corporation Budesonide (BUD) Products Offered
11.10.5 Synmosa Biopharma Corporation Related Developments
11.1 AstraZeneca
11.1.1 AstraZeneca Corporation Information
11.1.2 AstraZeneca Description and Business Overview
11.1.3 AstraZeneca Sales, Revenue and Gross Margin (2015-2020)
11.1.4 AstraZeneca Budesonide (BUD) Products Offered
11.1.5 AstraZeneca Related Developments
11.12 Shanghai Sine Promod Pharmaceutical
11.12.1 Shanghai Sine Promod Pharmaceutical Corporation Information
11.12.2 Shanghai Sine Promod Pharmaceutical Description and Business Overview
11.12.3 Shanghai Sine Promod Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
11.12.4 Shanghai Sine Promod Pharmaceutical Products Offered
11.12.5 Shanghai Sine Promod Pharmaceutical Related Developments

12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Budesonide (BUD) Market Estimates and Projections by Region
12.1.1 Global Budesonide (BUD) Sales Forecast by Regions 2021-2026
12.1.2 Global Budesonide (BUD) Revenue Forecast by Regions 2021-2026
12.2 North America Budesonide (BUD) Market Size Forecast (2021-2026)
12.2.1 North America: Budesonide (BUD) Sales Forecast (2021-2026)
12.2.2 North America: Budesonide (BUD) Revenue Forecast (2021-2026)
12.2.3 North America: Budesonide (BUD) Market Size Forecast by Country (2021-2026)
12.3 Europe Budesonide (BUD) Market Size Forecast (2021-2026)
12.3.1 Europe: Budesonide (BUD) Sales Forecast (2021-2026)
12.3.2 Europe: Budesonide (BUD) Revenue Forecast (2021-2026)
12.3.3 Europe: Budesonide (BUD) Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Budesonide (BUD) Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Budesonide (BUD) Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Budesonide (BUD) Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Budesonide (BUD) Market Size Forecast by Region (2021-2026)
12.5 Latin America Budesonide (BUD) Market Size Forecast (2021-2026)
12.5.1 Latin America: Budesonide (BUD) Sales Forecast (2021-2026)
12.5.2 Latin America: Budesonide (BUD) Revenue Forecast (2021-2026)
12.5.3 Latin America: Budesonide (BUD) Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Budesonide (BUD) Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Budesonide (BUD) Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Budesonide (BUD) Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Budesonide (BUD) Market Size Forecast by Country (2021-2026)

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Budesonide (BUD) Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Budesonide (BUD) Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer

List of Tables
Table 1. Budesonide (BUD) Market Segments
Table 2. Ranking of Global Top Budesonide (BUD) Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Budesonide (BUD) Market Size Growth Rate by Type 2020-2026 (K MT) & (US$ Million)
Table 4. Major Manufacturers of Nasal Spray
Table 5. Major Manufacturers of Inhaler
Table 6. Major Manufacturers of Pill&Rectal Forms
Table 7. Global Budesonide (BUD) Market Size Growth Rate by Application 2020-2026 (K MT)
Table 8. Global Budesonide (BUD) Market Size by Region (K MT) & (US$ Million): 2020 VS 2026
Table 9. Global Budesonide (BUD) Sales by Regions 2015-2020 (K MT)
Table 10. Global Budesonide (BUD) Sales Market Share by Regions (2015-2020)
Table 11. Global Budesonide (BUD) Revenue by Regions 2015-2020 (US$ Million)
Table 12. Global Budesonide (BUD) Sales by Manufacturers (2015-2020) (K MT)
Table 13. Global Budesonide (BUD) Sales Share by Manufacturers (2015-2020)
Table 14. Global Budesonide (BUD) Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 15. Global Budesonide (BUD) by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Budesonide (BUD) as of 2019)
Table 16. Budesonide (BUD) Revenue by Manufacturers (2015-2020) (US$ Million)
Table 17. Budesonide (BUD) Revenue Share by Manufacturers (2015-2020)
Table 18. Key Manufacturers Budesonide (BUD) Price (2015-2020) (USD/MT)
Table 19. Budesonide (BUD) Manufacturers Manufacturing Base Distribution and Headquarters
Table 20. Manufacturers Budesonide (BUD) Product Type
Table 21. Date of International Manufacturers Enter into Budesonide (BUD) Market
Table 22. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 23. Global Budesonide (BUD) Sales by Type (2015-2020) (K MT)
Table 24. Global Budesonide (BUD) Sales Share by Type (2015-2020)
Table 25. Global Budesonide (BUD) Revenue by Type (2015-2020) (US$ Million)
Table 26. Global Budesonide (BUD) Revenue Share by Type (2015-2020)
Table 27. Budesonide (BUD) Average Selling Price (ASP) by Type 2015-2020 (USD/MT)
Table 28. Global Budesonide (BUD) Sales by Application (2015-2020) (K MT)
Table 29. Global Budesonide (BUD) Sales Share by Application (2015-2020)
Table 30. North America Budesonide (BUD) Sales by Country (2015-2020) (K MT)
Table 31. North America Budesonide (BUD) Sales Market Share by Country (2015-2020)
Table 32. North America Budesonide (BUD) Revenue by Country (2015-2020) (US$ Million)
Table 33. North America Budesonide (BUD) Revenue Market Share by Country (2015-2020)
Table 34. North America Budesonide (BUD) Sales by Type (2015-2020) (K MT)
Table 35. North America Budesonide (BUD) Sales Market Share by Type (2015-2020)
Table 36. North America Budesonide (BUD) Sales by Application (2015-2020) (K MT)
Table 37. North America Budesonide (BUD) Sales Market Share by Application (2015-2020)
Table 38. Europe Budesonide (BUD) Sales by Country (2015-2020) (K MT)
Table 39. Europe Budesonide (BUD) Sales Market Share by Country (2015-2020)
Table 40. Europe Budesonide (BUD) Revenue by Country (2015-2020) (US$ Million)
Table 41. Europe Budesonide (BUD) Revenue Market Share by Country (2015-2020)
Table 42. Europe Budesonide (BUD) Sales by Type (2015-2020) (K MT)
Table 43. Europe Budesonide (BUD) Sales Market Share by Type (2015-2020)
Table 44. Europe Budesonide (BUD) Sales by Application (2015-2020) (K MT)
Table 45. Europe Budesonide (BUD) Sales Market Share by Application (2015-2020)
Table 46. Asia Pacific Budesonide (BUD) Sales by Region (2015-2020) (K MT)
Table 47. Asia Pacific Budesonide (BUD) Sales Market Share by Region (2015-2020)
Table 48. Asia Pacific Budesonide (BUD) Revenue by Region (2015-2020) (US$ Million)
Table 49. Asia Pacific Budesonide (BUD) Revenue Market Share by Region (2015-2020)
Table 50. Asia Pacific Budesonide (BUD) Sales by Type (2015-2020) (K MT)
Table 51. Asia Pacific Budesonide (BUD) Sales Market Share by Type (2015-2020)
Table 52. Asia Pacific Budesonide (BUD) Sales by Application (2015-2020) (K MT)
Table 53. Asia Pacific Budesonide (BUD) Sales Market Share by Application (2015-2020)
Table 54. Latin America Budesonide (BUD) Sales by Country (2015-2020) (K MT)
Table 55. Latin America Budesonide (BUD) Sales Market Share by Country (2015-2020)
Table 56. Latin Americaa Budesonide (BUD) Revenue by Country (2015-2020) (US$ Million)
Table 57. Latin America Budesonide (BUD) Revenue Market Share by Country (2015-2020)
Table 58. Latin America Budesonide (BUD) Sales by Type (2015-2020) (K MT)
Table 59. Latin America Budesonide (BUD) Sales Market Share by Type (2015-2020)
Table 60. Latin America Budesonide (BUD) Sales by Application (2015-2020) (K MT)
Table 61. Latin America Budesonide (BUD) Sales Market Share by Application (2015-2020)
Table 62. Middle East and Africa Budesonide (BUD) Sales by Country (2015-2020) (K MT)
Table 63. Middle East and Africa Budesonide (BUD) Sales Market Share by Country (2015-2020)
Table 64. Middle East and Africa Budesonide (BUD) Revenue by Country (2015-2020) (US$ Million)
Table 65. Middle East and Africa Budesonide (BUD) Revenue Market Share by Country (2015-2020)
Table 66. Middle East and Africa Budesonide (BUD) Sales by Type (2015-2020) (K MT)
Table 67. Middle East and Africa Budesonide (BUD) Sales Market Share by Type (2015-2020)
Table 68. Middle East and Africa Budesonide (BUD) Sales by Application (2015-2020) (K MT)
Table 69. Middle East and Africa Budesonide (BUD) Sales Market Share by Application (2015-2020)
Table 70. AstraZeneca Corporation Information
Table 71. AstraZeneca Description and Major Businesses
Table 72. AstraZeneca Budesonide (BUD) Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 73. AstraZeneca Product
Table 74. AstraZeneca Recent Development
Table 75. Cosmo Pharmaceuticals Corporation Information
Table 76. Cosmo Pharmaceuticals Description and Major Businesses
Table 77. Cosmo Pharmaceuticals Budesonide (BUD) Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 78. Cosmo Pharmaceuticals Product
Table 79. Cosmo Pharmaceuticals Recent Development
Table 80. Teva Corporation Information
Table 81. Teva Description and Major Businesses
Table 82. Teva Budesonide (BUD) Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 83. Teva Product
Table 84. Teva Recent Development
Table 85. Mylan Corporation Information
Table 86. Mylan Description and Major Businesses
Table 87. Mylan Budesonide (BUD) Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 88. Mylan Product
Table 89. Mylan Recent Development
Table 90. Sandoz Corporation Information
Table 91. Sandoz Description and Major Businesses
Table 92. Sandoz Budesonide (BUD) Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 93. Sandoz Product
Table 94. Sandoz Recent Development
Table 95. Dr. Falk Pharma Corporation Information
Table 96. Dr. Falk Pharma Description and Major Businesses
Table 97. Dr. Falk Pharma Budesonide (BUD) Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 98. Dr. Falk Pharma Product
Table 99. Dr. Falk Pharma Recent Development
Table 100. Chiesi Farmaceutici S.p.A Corporation Information
Table 101. Chiesi Farmaceutici S.p.A Description and Major Businesses
Table 102. Chiesi Farmaceutici S.p.A Budesonide (BUD) Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 103. Chiesi Farmaceutici S.p.A Product
Table 104. Chiesi Farmaceutici S.p.A Recent Development
Table 105. Orion Corporation Corporation Information
Table 106. Orion Corporation Description and Major Businesses
Table 107. Orion Corporation Budesonide (BUD) Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 108. Orion Corporation Product
Table 109. Orion Corporation Recent Development
Table 110. Cipla Corporation Information
Table 111. Cipla Description and Major Businesses
Table 112. Cipla Budesonide (BUD) Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 113. Cipla Product
Table 114. Cipla Recent Development
Table 115. Synmosa Biopharma Corporation Corporation Information
Table 116. Synmosa Biopharma Corporation Description and Major Businesses
Table 117. Synmosa Biopharma Corporation Budesonide (BUD) Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 118. Synmosa Biopharma Corporation Product
Table 119. Synmosa Biopharma Corporation Recent Development
Table 120. Lunan Better Pharmaceutical Corporation Information
Table 121. Lunan Better Pharmaceutical Description and Major Businesses
Table 122. Lunan Better Pharmaceutical Budesonide (BUD) Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 123. Lunan Better Pharmaceutical Product
Table 124. Lunan Better Pharmaceutical Recent Development
Table 125. Shanghai Sine Promod Pharmaceutical Corporation Information
Table 126. Shanghai Sine Promod Pharmaceutical Description and Major Businesses
Table 127. Shanghai Sine Promod Pharmaceutical Budesonide (BUD) Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 128. Shanghai Sine Promod Pharmaceutical Product
Table 129. Shanghai Sine Promod Pharmaceutical Recent Development
Table 130. Global Budesonide (BUD) Sales Forecast by Regions (2021-2026) (K MT)
Table 131. Global Budesonide (BUD) Sales Market Share Forecast by Regions (2021-2026)
Table 132. Global Budesonide (BUD) Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 133. Global Budesonide (BUD) Revenue Market Share Forecast by Regions (2021-2026)
Table 134. North America: Budesonide (BUD) Sales Forecast by Country (2021-2026) (K MT)
Table 135. North America: Budesonide (BUD) Revenue Forecast by Country (2021-2026) (US$ Million)
Table 136. Europe: Budesonide (BUD) Sales Forecast by Country (2021-2026) (K MT)
Table 137. Europe: Budesonide (BUD) Revenue Forecast by Country (2021-2026) (US$ Million)
Table 138. Asia Pacific: Budesonide (BUD) Sales Forecast by Region (2021-2026) (K MT)
Table 139. Asia Pacific: Budesonide (BUD) Revenue Forecast by Region (2021-2026) (US$ Million)
Table 140. Latin America: Budesonide (BUD) Sales Forecast by Country (2021-2026) (K MT)
Table 141. Latin America: Budesonide (BUD) Revenue Forecast by Country (2021-2026) (US$ Million)
Table 142. Middle East and Africa: Budesonide (BUD) Sales Forecast by Country (2021-2026) (K MT)
Table 143. Middle East and Africa: Budesonide (BUD) Revenue Forecast by Country (2021-2026) (US$ Million)
Table 144. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 145. Key Challenges
Table 146. Market Risks
Table 147. Main Points Interviewed from Key Budesonide (BUD) Players
Table 148. Budesonide (BUD) Customers List
Table 149. Budesonide (BUD) Distributors List
Table 150. Research Programs/Design for This Report
Table 151. Key Data Information from Secondary Sources
Table 152. Key Data Information from Primary Sources
List of Figures
Figure 1. Budesonide (BUD) Product Picture
Figure 2. Global Budesonide (BUD) Sales Market Share by Type in 2020 & 2026
Figure 3. Nasal Spray Product Picture
Figure 4. Inhaler Product Picture
Figure 5. Pill&Rectal Forms Product Picture
Figure 6. Global Budesonide (BUD) Sales Market Share by Application in 2020 & 2026
Figure 7. Respiratory Disease Treatment
Figure 8. Nose Disease Treatment
Figure 9. Inflammatory Bowel Disease Treatment
Figure 10. Budesonide (BUD) Report Years Considered
Figure 11. Global Budesonide (BUD) Market Size 2015-2026 (US$ Million)
Figure 12. Global Budesonide (BUD) Sales 2015-2026 (K MT)
Figure 13. Global Budesonide (BUD) Market Size Market Share by Region: 2020 Versus 2026
Figure 14. Global Budesonide (BUD) Sales Market Share by Region (2015-2020)
Figure 15. Global Budesonide (BUD) Sales Market Share by Region in 2019
Figure 16. Global Budesonide (BUD) Revenue Market Share by Region (2015-2020)
Figure 17. Global Budesonide (BUD) Revenue Market Share by Region in 2019
Figure 18. Global Budesonide (BUD) Sales Share by Manufacturer in 2019
Figure 19. The Top 10 and 5 Players Market Share by Budesonide (BUD) Revenue in 2019
Figure 20. Budesonide (BUD) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 21. Global Budesonide (BUD) Sales Market Share by Type (2015-2020)
Figure 22. Global Budesonide (BUD) Sales Market Share by Type in 2019
Figure 23. Global Budesonide (BUD) Revenue Market Share by Type (2015-2020)
Figure 24. Global Budesonide (BUD) Revenue Market Share by Type in 2019
Figure 25. Global Budesonide (BUD) Market Share by Price Range (2015-2020)
Figure 26. Global Budesonide (BUD) Sales Market Share by Application (2015-2020)
Figure 27. Global Budesonide (BUD) Sales Market Share by Application in 2019
Figure 28. Global Budesonide (BUD) Revenue Market Share by Application (2015-2020)
Figure 29. Global Budesonide (BUD) Revenue Market Share by Application in 2019
Figure 30. North America Budesonide (BUD) Sales Growth Rate 2015-2020 (K MT)
Figure 31. North America Budesonide (BUD) Revenue Growth Rate 2015-2020 (US$ Million)
Figure 32. North America Budesonide (BUD) Sales Market Share by Country in 2019
Figure 33. North America Budesonide (BUD) Revenue Market Share by Country in 2019
Figure 34. U.S. Budesonide (BUD) Sales Growth Rate (2015-2020) (K MT)
Figure 35. U.S. Budesonide (BUD) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 36. Canada Budesonide (BUD) Sales Growth Rate (2015-2020) (K MT)
Figure 37. Canada Budesonide (BUD) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 38. North America Budesonide (BUD) Market Share by Type in 2019
Figure 39. North America Budesonide (BUD) Market Share by Application in 2019
Figure 40. Europe Budesonide (BUD) Sales Growth Rate 2015-2020 (K MT)
Figure 41. Europe Budesonide (BUD) Revenue Growth Rate 2015-2020 (US$ Million)
Figure 42. Europe Budesonide (BUD) Sales Market Share by Country in 2019
Figure 43. Europe Budesonide (BUD) Revenue Market Share by Country in 2019
Figure 44. Germany Budesonide (BUD) Sales Growth Rate (2015-2020) (K MT)
Figure 45. Germany Budesonide (BUD) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 46. France Budesonide (BUD) Sales Growth Rate (2015-2020) (K MT)
Figure 47. France Budesonide (BUD) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. U.K. Budesonide (BUD) Sales Growth Rate (2015-2020) (K MT)
Figure 49. U.K. Budesonide (BUD) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. Italy Budesonide (BUD) Sales Growth Rate (2015-2020) (K MT)
Figure 51. Italy Budesonide (BUD) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Russia Budesonide (BUD) Sales Growth Rate (2015-2020) (K MT)
Figure 53. Russia Budesonide (BUD) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Europe Budesonide (BUD) Market Share by Type in 2019
Figure 55. Europe Budesonide (BUD) Market Share by Application in 2019
Figure 56. Asia Pacific Budesonide (BUD) Sales Growth Rate 2015-2020 (K MT)
Figure 57. Asia Pacific Budesonide (BUD) Revenue Growth Rate 2015-2020 (US$ Million)
Figure 58. Asia Pacific Budesonide (BUD) Sales Market Share by Region in 2019
Figure 59. Asia Pacific Budesonide (BUD) Revenue Market Share by Region in 2019
Figure 60. China Budesonide (BUD) Sales Growth Rate (2015-2020) (K MT)
Figure 61. China Budesonide (BUD) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 62. Japan Budesonide (BUD) Sales Growth Rate (2015-2020) (K MT)
Figure 63. Japan Budesonide (BUD) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. South Korea Budesonide (BUD) Sales Growth Rate (2015-2020) (K MT)
Figure 65. South Korea Budesonide (BUD) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. India Budesonide (BUD) Sales Growth Rate (2015-2020) (K MT)
Figure 67. India Budesonide (BUD) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. Australia Budesonide (BUD) Sales Growth Rate (2015-2020) (K MT)
Figure 69. Australia Budesonide (BUD) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Taiwan Budesonide (BUD) Sales Growth Rate (2015-2020) (K MT)
Figure 71. Taiwan Budesonide (BUD) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Indonesia Budesonide (BUD) Sales Growth Rate (2015-2020) (K MT)
Figure 73. Indonesia Budesonide (BUD) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Thailand Budesonide (BUD) Sales Growth Rate (2015-2020) (K MT)
Figure 75. Thailand Budesonide (BUD) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Malaysia Budesonide (BUD) Sales Growth Rate (2015-2020) (K MT)
Figure 77. Malaysia Budesonide (BUD) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Philippines Budesonide (BUD) Sales Growth Rate (2015-2020) (K MT)
Figure 79. Philippines Budesonide (BUD) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Vietnam Budesonide (BUD) Sales Growth Rate (2015-2020) (K MT)
Figure 81. Vietnam Budesonide (BUD) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Asia Pacific Budesonide (BUD) Market Share by Type in 2019
Figure 83. Asia Pacific Budesonide (BUD) Market Share by Application in 2019
Figure 84. Latin America Budesonide (BUD) Sales Growth Rate 2015-2020 (K MT)
Figure 85. Latin America Budesonide (BUD) Revenue Growth Rate 2015-2020 (US$ Million)
Figure 86. Latin America Budesonide (BUD) Sales Market Share by Country in 2019
Figure 87. Latin America Budesonide (BUD) Revenue Market Share by Country in 2019
Figure 88. Mexico Budesonide (BUD) Sales Growth Rate (2015-2020) (K MT)
Figure 89. Mexico Budesonide (BUD) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 90. Brazil Budesonide (BUD) Sales Growth Rate (2015-2020) (K MT)
Figure 91. Brazil Budesonide (BUD) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 92. Argentina Budesonide (BUD) Sales Growth Rate (2015-2020) (K MT)
Figure 93. Argentina Budesonide (BUD) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 94. Latin America Budesonide (BUD) Market Share by Type in 2019
Figure 95. Latin America Budesonide (BUD) Market Share by Application in 2019
Figure 96. Middle East and Africa Budesonide (BUD) Sales Growth Rate 2015-2020 (K MT)
Figure 97. Middle East and Africa Budesonide (BUD) Revenue Growth Rate 2015-2020 (US$ Million)
Figure 98. Middle East and Africa Budesonide (BUD) Sales Market Share by Country in 2019
Figure 99. Middle East and Africa Budesonide (BUD) Revenue Market Share by Country in 2019
Figure 100. Turkey Budesonide (BUD) Sales Growth Rate (2015-2020) (K MT)
Figure 101. Turkey Budesonide (BUD) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 102. Saudi Arabia Budesonide (BUD) Sales Growth Rate (2015-2020) (K MT)
Figure 103. Saudi Arabia Budesonide (BUD) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 104. U.A.E Budesonide (BUD) Sales Growth Rate (2015-2020) (K MT)
Figure 105. U.A.E Budesonide (BUD) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 106. Middle East and Africa Budesonide (BUD) Market Share by Type in 2019
Figure 107. Middle East and Africa Budesonide (BUD) Market Share by Application in 2019
Figure 108. North America Budesonide (BUD) Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 109. North America Budesonide (BUD) Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 110. Europe Budesonide (BUD) Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 111. Europe Budesonide (BUD) Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 112. Asia Pacific Budesonide (BUD) Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 113. Asia Pacific Budesonide (BUD) Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 114. Latin America Budesonide (BUD) Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 115. Latin America Budesonide (BUD) Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 116. Middle East and Africa Budesonide (BUD) Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 117. Middle East and Africa Budesonide (BUD) Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 118. Porter's Five Forces Analysis
Figure 119. Channels of Distribution
Figure 120. Distributors Profiles
Figure 121. Bottom-up and Top-down Approaches for This Report
Figure 122. Data Triangulation
Figure 123. Key Executives Interviewed

---